Search Results - "Cook RS"

In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers.

Authors: Siame, Courage Ofori, Benedict Paemka, Lily Adzo et al.

Source: PLoS ONE. 5/6/2026, Vol. 21 Issue 5, p1-17. 17p.

Author Correction: Drug response in organoids generated from frozen primary tumor tissues.

Authors: Walsh AJ Cook RS Sanders ME et al.

Source: Scientific reports [Sci Rep] 2019 Apr 24; Vol. 9 (1), pp. 6517. Date of Electronic Publication: 2019 Apr 24.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: PubMed not MEDLINE

Radioluminescence microscopy of tumor organoids enabled by a reconfigurable high-resolution imaging setup.

Authors: Demianova, Sofia Dierolf, Martin Reichert, Maximilian et al.

Source: EJNMMI Research. 7/7/2026, Vol. 16 Issue 1, p1-9. 9p.

Prevalence of multiple morbidities and cancers in individuals with Down syndrome: A matched descriptive study using linked electronic health record data.

Authors: McKenna, Caoimhe Khanna, Kabir Yoshinori Cupp, Meghan A. et al.

Source: PLoS ONE. 6/3/2026, Vol. 21 Issue 6, p1-23. 23p.

Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies.

Authors: Haq, Burhan Ul Sofi, Shazia Qayoom, Hina et al.

Source: PLoS ONE. 12/5/2025, Vol. 20 Issue 12, p1-27. 27p.

MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer.

Authors: Barbeau, Lydie M. O. Beelen, Nicky A. Savelkouls, Kim G. et al.

Source: PLoS ONE. 2/10/2025, Vol. 20 Issue 2, p1-19. 19p.

Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.

Authors: Kratz, Jeremy D. Rehman, Shujah Johnson, Katherine A. et al.

Source: Scientific Reports. 4/9/2025, Vol. 15 Issue 1, p1-17. 17p.

siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigs.

Authors: Colazo JM Keech MC Shah V et al.

Source: Nature biomedical engineering [Nat Biomed Eng] 2025 Aug; Vol. 9 (8), pp. 1366-1383. Date of Electronic Publication: 2025 May 16.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

Small Extracellular Vesicles From Platelet-Rich and Platelet-Poor Plasma Are Primarily From Platelets and Protect Synoviocytes From IL-1β–Induced Inflammation.

Authors: Piening, Logan Wolfe, Preston Shepard, David et al.

Source: American Journal of Sports Medicine. Dec2025, Vol. 53 Issue 14, p3462-3473.

Upper endoscopy in Solomon Islands: A four-year retrospective study.

Authors: Bush, Dylan M Kohia, Stallone Garcia Hernandez, Adrian et al.

Source: Science Progress. Jul-Sep2025, Vol. 108 Issue 3, p1-15. 15p.

Probing the link between vision and language in material perception using psychophysics and unsupervised learning.

Authors: Liao, Chenxi Sawayama, Masataka Xiao, Bei

Source: PLoS Computational Biology. 10/3/2024, Vol. 20 Issue 10, p1-23. 23p.

Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework.

Authors: Gunnarsson, Einar Bjarki Kim, Seungil Choi, Brandon et al.

Source: PLoS Computational Biology. 8/2/2024, Vol. 20 Issue 8, p1-26. 26p.

KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis.

Authors: Yao, Jie Zhou, Changshuai Ding, Liren

Source: PLoS ONE. 6/21/2026, Vol. 21 Issue 6, p1-14. 14p.

YKL-40 inhibits melanoma progression and metastasis by inducing immune cell infiltration in a mouse model.

Authors: Zhang, Hailong Zhao, Xiangyu Shi, Mengqi et al.

Source: Scientific Reports. 3/3/2025, Vol. 15 Issue 1, p1-12. 12p.

Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation Landscape.

Authors: Wang, Yixuan Zhang, Lianru Du, Yanan et al.

Source: OncoTargets & Therapy. Mar2025, Vol. 18, p429-439. 11p.

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.

Authors: Ko, Dongmi Park, Soeun Park, Minsu et al.

Source: Experimental Hematology & Oncology. 10/22/2025, Vol. 14 Issue 1, p1-20. 20p.

LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.

Authors: Qiu, Minghan Gao, Zhanhua Tian, Mengran et al.

Source: Cell Communication & Signaling. 10/8/2025, Vol. 23 Issue 1, p1-18. 18p.

The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms.

Authors: Ansari, Mohammad Nafees Jha, Somesh K. Khan, Ali et al.

Source: PLoS Biology. 9/11/2025, Vol. 23 Issue 9, p1-35. 35p.

Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.

Authors: Kong, Yifan Li, Chaohao Liu, Jinpeng et al.

Source: PLoS Genetics. 6/17/2024, Vol. 20 Issue 6, p1-23. 23p.

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.

Authors: Divoux, Jordane Florent, Romane Jacobs, Margaux et al.

Source: BMC Cancer. 9/19/2023, Vol. 23 Issue 1, p1-8. 8p.